The cGAS–STING Pathway in Diabetic Retinopathy and age-related Macular Degeneration
Future Medicinal Chemistry · 2023
DOI: 10.4155/fmc-2022-0301 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, 2023. Verfasst von Bo Hu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Macular Degeneration, Retinal Diseases, Diabetes Mellitus. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, National Eye Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA.
- Department of Biochemistry, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA.
ORCID-Profile: Bo Hu, Jian-Xing Ma, Adam S Duerfeldt
Förderung
- NEI NIH HHS
- National Eye Institute
Zitieren
APA
Hu, B., Ma, J. X., & Duerfeldt, A. S. (2023). The cGAS–STING Pathway in Diabetic Retinopathy and age-related Macular Degeneration. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2022-0301
Vancouver
Hu B, Ma JX, Duerfeldt AS. The cGAS–STING Pathway in Diabetic Retinopathy and age-related Macular Degeneration. Future Medicinal Chemistry. 2023. doi:10.4155/fmc-2022-0301
BibTeX
@article{Hu2023,
author = {Hu, Bo and Ma, Jian-Xing and Duerfeldt, Adam S},
title = {The cGAS–STING Pathway in Diabetic Retinopathy and age-related Macular Degeneration},
journal = {Future Medicinal Chemistry},
year = {2023},
doi = {10.4155/fmc-2022-0301}
}
EUVIMED